Similar articles

• The therapy of renal adenocarcinoma with immune RNA.

  deKernion JB, Ramming KP. deKernion JB, et al. Invest Urol. 1980 Mar;17(5):378-81. Invest Urol. 1980. PMID: 7358501
• Current status of chemotherapy, hormonal therapy, and immunotherapy in the treatment of renal cell carcinoma.

  Poster DS, Bruno S, Penta JS, Pinna K, Vilk P, Macdonald JS. Poster DS, et al. Am J Clin Oncol. 1982 Feb;5(1):53-60. Am J Clin Oncol. 1982. PMID: 7081138
• [Clinical course and remote results in treatment of the renal parenchymal tumors].

  Lerner GIa, Lykov VN, Naumov MM, Sultanbaev RA. Lerner GIa, et al. Urol Nefrol (Mosk). 1978 May-Jun;(3):70-3. Urol Nefrol (Mosk). 1978. PMID: 664130 Russian. No abstract available.
• Immunotherapeutic approaches for renal cancer.

  Pizza G, de Vinci C, Viza D. Pizza G, et al. Folia Biol (Praha). 2002;48(5):167-81. Folia Biol (Praha). 2002. PMID: 12448765 Review. No abstract available.
• Management of renal carcinoma.

  Whitehead ED. Whitehead ED. N Y State J Med. 1981 May;81(6):911-4. N Y State J Med. 1981. PMID: 6785679 Review. No abstract available.